D. E. Shaw & Co. Inc. Buys 301,295 Shares of Nu Skin Enterprises, Inc. (NYSE:NUS)

D. E. Shaw & Co. Inc. grew its holdings in Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 15.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,251,352 shares of the company's stock after acquiring an additional 301,295 shares during the period. D. E. Shaw & Co. Inc. owned 4.53% of Nu Skin Enterprises worth $15,512,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in NUS. Barclays PLC raised its position in Nu Skin Enterprises by 363.8% in the third quarter. Barclays PLC now owns 85,437 shares of the company's stock worth $629,000 after acquiring an additional 67,016 shares during the period. JPMorgan Chase & Co. raised its position in shares of Nu Skin Enterprises by 175.6% during the 3rd quarter. JPMorgan Chase & Co. now owns 231,957 shares of the company's stock valued at $1,710,000 after purchasing an additional 147,784 shares during the period. Ballentine Partners LLC raised its position in shares of Nu Skin Enterprises by 15.5% during the 4th quarter. Ballentine Partners LLC now owns 20,856 shares of the company's stock valued at $144,000 after purchasing an additional 2,800 shares during the period. Inspire Investing LLC raised its position in shares of Nu Skin Enterprises by 7.8% during the 4th quarter. Inspire Investing LLC now owns 65,418 shares of the company's stock valued at $451,000 after purchasing an additional 4,728 shares during the period. Finally, Rhumbline Advisers raised its position in shares of Nu Skin Enterprises by 70.9% during the 4th quarter. Rhumbline Advisers now owns 138,477 shares of the company's stock valued at $954,000 after purchasing an additional 57,443 shares during the period. 82.84% of the stock is currently owned by institutional investors.

Nu Skin Enterprises Price Performance

NYSE NUS traded up $0.12 on Friday, reaching $7.59. The company had a trading volume of 378,960 shares, compared to its average volume of 835,574. The company has a quick ratio of 1.17, a current ratio of 1.82 and a debt-to-equity ratio of 0.56. The stock has a market capitalization of $377.40 million, a PE ratio of -2.57 and a beta of 0.92. The firm's 50 day moving average price is $6.66 and its 200 day moving average price is $6.98. Nu Skin Enterprises, Inc. has a 12 month low of $5.32 and a 12 month high of $13.90.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $0.23 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.15 by $0.08. The company had revenue of $364.49 million for the quarter, compared to the consensus estimate of $352.06 million. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. As a group, equities analysts predict that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current year.

Nu Skin Enterprises Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 11th. Shareholders of record on Friday, May 30th will be issued a $0.06 dividend. The ex-dividend date of this dividend is Friday, May 30th. This represents a $0.24 dividend on an annualized basis and a yield of 3.16%. Nu Skin Enterprises's dividend payout ratio is currently -30.00%.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded shares of Nu Skin Enterprises from a "hold" rating to a "buy" rating in a research report on Monday, May 12th.

Nu Skin Enterprises Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.